简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

OptiNose Inc <OPTN.OQ> expected to post a loss of 72 cents a share - Earnings Preview

2025-03-03 21:46

  • OptiNose Inc OPTN.OQ OPTN.O is expected to show a rise in quarterly revenue when it reports results on March 5 (estimated) for the period ending December 31 2024

  • The Yardley Pennsylvania-based company is expected to report a 12.3% increase in revenue to $22.307 million from $19.87 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $19.00 million and $23.00 million.

  • ​LSEG's mean analyst estimate for OptiNose Inc is for a loss of 72 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for OptiNose Inc is $17.50​, above​ its last closing price of $5.81. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.79

-0.79

0.00

Beat

100

Jun. 30 2024

-1.11

-1.16

-0.75

Beat

35.3

Mar. 31 2024

-1.63

-1.61

-1.80

Missed

-11.6​

Dec. 31 2023

-1.42

-1.41

-1.35

Beat

4.6

​​Sep. 30 2023

-1.42

-1.41

-1.20

Beat

15.2

Jun. 30 2023

-1.61

-1.63

0.30

Beat

118.4​

Mar. 31 2023

-2.06

-2.09

-2.55

Missed

-22

Dec. 31 2022

-2.60

-2.62

-2.55

Beat

2.7

This summary was machine generated March 3 at 13:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。